Examining the power of modern interventions in alleviating symptoms of Parkinson’s disease

​Parkinson's disease  is a progressive neurological disorder that affects movement, causing symptoms such as tremors, stiffness, and balance issues. While there is currently no cure, recent advancements in medical interventions have significantly improved symptom management and enhanced patients' quality of life.

​

Medications

Levodopa, often combined with carbidopa, remains the cornerstone of PD treatment, effectively alleviating motor symptoms. In August 2024, the FDA approved Crexont, an extended-release formulation of levodopa/carbidopa, offering longer-lasting symptom control and reducing dosing frequency. ​

Additionally, foslevodopa-foscarbidopa (Produodopa) received approval in Europe in October 2023 for individuals experiencing movement-related symptoms, providing another therapeutic option. ​

Deep Brain Stimulation (DBS)

DBS has been a transformative surgical intervention for PD patients with advanced symptoms unresponsive to medication. In February 2025, the FDA approved Medtronic's BrainSense Adaptive DBS system, which dynamically adjusts stimulation in response to real-time brain signals, enhancing symptom management and potentially reducing side effects. ​

Gene Therapy

Emerging gene therapy approaches show promise in addressing PD symptoms and potentially modifying disease progression. Preclinical studies have demonstrated that certain gene therapies can reverse motor symptoms and may halt disease advancement, though further research is needed to confirm these findings in clinical settings. ​

Innovative Therapies

Research into repurposing existing drugs has uncovered potential new treatments for PD. For instance, studies suggest that certain cancer drugs could target proteins implicated in PD, offering a novel therapeutic avenue. ​

Furthermore, advancements in drug delivery systems, such as continuous pump medications like PRODUODOPA (VYALEV in the U.S.), have been developed to provide steady medication levels, reducing motor fluctuations and improving symptom control. ​

Complementary Approaches

Innovative non-pharmacological interventions are also being explored. For example, combining physical therapy with artistic activities has shown potential in enhancing motor function and patient engagement. A study at the University of Connecticut integrated art creation into gait training, resulting in improved mobility and motivation among participants. ​

These advancements reflect a multifaceted approach to PD treatment, focusing on personalized care strategies that combine pharmacological, surgical, and supportive therapies to optimize patient outcomes.